Cargando…

Treatment options for hypertension in high-risk patients

Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients si...

Descripción completa

Detalles Bibliográficos
Autor principal: Tsai, Wei-Chuan
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064455/
https://www.ncbi.nlm.nih.gov/pubmed/21468174
http://dx.doi.org/10.2147/VHRM.S11235
_version_ 1782200892613722112
author Tsai, Wei-Chuan
author_facet Tsai, Wei-Chuan
author_sort Tsai, Wei-Chuan
collection PubMed
description Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients significantly. Identification of high-risk patients by global risk evaluation is recommended for every hypertensive patient. Treatment of hypertension in high-risk patients with an angiotensin-converting enzyme inhibitor or an angiotensin receptor antagonist, with or without addition of a dihydropyridine calcium channel antagonist, is a reasonable approach based on current clinical trials.
format Text
id pubmed-3064455
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30644552011-04-05 Treatment options for hypertension in high-risk patients Tsai, Wei-Chuan Vasc Health Risk Manag Review Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients significantly. Identification of high-risk patients by global risk evaluation is recommended for every hypertensive patient. Treatment of hypertension in high-risk patients with an angiotensin-converting enzyme inhibitor or an angiotensin receptor antagonist, with or without addition of a dihydropyridine calcium channel antagonist, is a reasonable approach based on current clinical trials. Dove Medical Press 2011 2011-03-09 /pmc/articles/PMC3064455/ /pubmed/21468174 http://dx.doi.org/10.2147/VHRM.S11235 Text en © 2011 Tsai, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Tsai, Wei-Chuan
Treatment options for hypertension in high-risk patients
title Treatment options for hypertension in high-risk patients
title_full Treatment options for hypertension in high-risk patients
title_fullStr Treatment options for hypertension in high-risk patients
title_full_unstemmed Treatment options for hypertension in high-risk patients
title_short Treatment options for hypertension in high-risk patients
title_sort treatment options for hypertension in high-risk patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064455/
https://www.ncbi.nlm.nih.gov/pubmed/21468174
http://dx.doi.org/10.2147/VHRM.S11235
work_keys_str_mv AT tsaiweichuan treatmentoptionsforhypertensioninhighriskpatients